Nikkiso Clean Energy & Industrial Gases Group Announces a Complete Liquid Hydrogen Bunkering Installation for Unitrove

TEMECULA, Calif., Dec. 07, 2021 (GLOBE NEWSWIRE) — Nikkiso Cryogenic Industries’ Clean Energy & Industrial Gases Group (Group), a subsidiary of Nikkiso Co., Ltd (Japan), is proud to announce our participation in the bunkering installation design of a new complete Liquid Hydrogen (LH2) Bunkering installation with Unitrove.

Nikkiso CE&IG and Unitrove are working together to develop solutions for the future, particularly regarding LH2. For this project, the Group provided custom equipment from two of its Functional Units: a sump from its Heat Exchangers unit (Cryoquip) and Cryogenic Pumps unit (ACD).

“We are excited and proud to be part of one of the world’s first liquid hydrogen (LH2) bunkering facility projects and the drive toward more energy-efficient solutions for the Marine market,” according to Ole Jensen, Vice President, Europe, Nikkiso Clean Energy & Industrial Gases Group.

The Bunkering system is being showcased at the United Nations COP26 Environmental Conference in Glasgow, which runs through November 12, 2021. The installation is expected to be completed sometime in 2022.

This will be the first of several expected projects to be delivered in 2022.

ABOUT CRYOGENIC INDUSTRIES
Cryogenic Industries, Inc. (now a member of Nikkiso Co., Ltd.) member companies manufacture engineered cryogenic gas processing equipment and small-scale process plants for the liquefied natural gas (LNG), well services and industrial gas industries. Founded over 50 years ago, Cryogenic Industries is the parent company of ACD, Cosmodyne and Cryoquip and a commonly controlled group of approximately 20 operating entities.

For more information, please visit www.nikkisoCEIG.com and www.nikkiso.com.

MEDIA CONTACT:
Anna Quigley
+1.951.383.3314
aquigley@cryoind.com

Interactive Mirror Allows Retail Customers to Virtually “Try On” Clothing

CALGARY, Alberta, Dec. 07, 2021 (GLOBE NEWSWIRE) — Retail clothing stores of the future will likely have fewer clothes, checkout stations, fitting rooms, employees—and square footage. Instead, you’re likely to see more self-service consoles that allow shoppers to virtually “try on” any garment.

According to NOBAL Technologies, Inc., of Calgary, that future is here right now, with NOBAL’s iMirror product, an interactive mirror that promises to revolutionize the customer experience in the retail realm—much as it’s already doing in hospitality settings.

Explains Royal Bissell, NOBAL’s Director of Innovation, “With a few taps by a customer, the iMirror’s built-in 3D camera takes an accurate full body scan, from which the shopper can create a lifelike avatar of themselves. They can then browse products on the iMirror, and, using their avatar, see exactly how garments will actually look and fit on their body.”

Customers can make purchases directly on the iMirror. NOBAL is reportedly working on a Tap to Pay solution to further facilitate the ecommerce functionality of the iMirror.

According to NOBAL’s Director of Technology, Daniel Maher, unlike other body modelling software whose avatars end up looking cartoonish, “The photo scan taken by the iMirror contains over 200 measurement points, yielding a photo-realistic avatar that’s 94% “measurement-accurate.” When that avatar is clothed in garments with similarly precise measurements, the customer can see exactly how that garment will look—and fit—on them.”

A big plus, reports NOBAL, is that once an avatar is created, a customer can download it to their smart phone, and use it on future visits to any store employing the same technology.

Adds Bissell, “The convenience for the customer is huge: they can instantly see what multiple garments look like on them, minus the time-intensive process of a physical fitting room.”

In the wake of the pandemic, and thanks to innovations like the iMirror, many retailers won’t be bringing back actual fitting rooms. The benefits, note Bissell, are many: “No fitting rooms means dramatically reduced shrinkage. Plus, with no fitting rooms and fewer—or no—checkout counters, a store’s total footprint can be much smaller. Then, there’s the accuracy of our imaging technology, which means better ‘virtual fits’ which, in turn, means far fewer returns.”

Another powerful benefit for retailers, according to NOBAL, is an increased “basket size.” Says Bissell, “With physical fitting rooms, a customer is deciding based on the limited garments available in the store where they’re trying on. In the virtual fitting room, the iMirror can make suggestions based on what the customer has already viewed, as well as the entire store’s inventory or even warehouse items — which are linked to the iMirror.”

NOBAL CEO, Bill Roberts, adds, “Customer satisfaction increases as retailers now have an endless aisle of offerings—even if those garments aren’t physically in the store.” Roberts also notes that their retail customers have reported basket-size jumps of 15-20% by using the iMirror, adding, “They’re discovering their ROI on the product is less than one week.”

According to the company, there may also be a psychological aspect to the proven basket-size increases the iMirror is delivering. Notes Bissell, “We haven’t fully unpacked this idea, but we suspect customers may purchase more items when they’re viewing them virtually, while those trying on actual clothes are more likely to decide not to purchase a given item or items.”

When it comes to the 3D images of clothing that customers’ avatars will “try on,” retailers reportedly can provide their own image library, or NOBAL, using their 3D-imaging technology, can help retailers create those libraries.

Bissell sums up: “We want to replicate the real fitting-room experience and the confidence that comes from physically trying on a garment and knowing that it fits. That’s now possible, given the accuracy of our system. It all adds up to a cost-effective solution with multiple substantive benefits for both customers and retailers.”

For more information on NOBAL’s leading-edge iMirror products, visit www.NOBAL.ca or contact:

Ms. Lindsay Panchyshyn, Director of Marketing
NOBAL Technologies Inc.
403-589-3322 | www.nobal.ca | lpanchyshyn@nobal.ca

Eyenuk Launches EyeArt AI System in South Africa in Collaboration with Discovery Health

A new diabetic retinopathy screening benefit enabled by the EyeArt® AI system is made available by Discovery Health, a global leader in Healthcare and Financial Services

LOS ANGELES, Dec. 07, 2021 (GLOBE NEWSWIRE) — Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening™ and AI Predictive Biomarkers™, announces today that Discovery Health launched a new Diabetic Retinopathy Screening Benefit nationwide in South Africa, powered by the cutting-edge EyeArt® AI System helping enable the detection of the onset of diabetic retinopathy as early as possible.

By launching the new Diabetic Retinopathy Screening Benefit, Discovery Health Medical Scheme (DHMS) simplifies access to screening for diabetic retinopathy and introduces cutting-edge AI-driven technology to the process. The Diabetic Retinopathy Screening Benefit follows a simple, three-level process: primary grading by the EyeArt AI System, and if required, secondary grading by an optometrist, and tertiary grading by an ophthalmologist.

“Discovery Health has always focused on incentivising, simplifying and enhancing member access to evidence-based preventative healthcare screening,” says CEO of Discovery Health, Dr. Ryan Noach. “The DHMS Diabetic Retinopathy Screening Benefit is fully aligned to this ethos. It gives members easy access to annual screening, which is conducted using cutting-edge AI technology, followed up by a clear referral process, and supported by scheme benefits requiring no member out-of-pocket payments for primary and secondary grading. Through this benefit, we hope to increase the number of DHMS members who are screened for diabetic retinopathy.”

Frank Cheng, Eyenuk President and CCO, added, “We applaud Discovery Health’s leadership for being the first payor to bring our EyeArt AI system to South Africa. The EyeArt AI System is the most extensively validated and adopted AI system for autonomous diabetic retinopathy detection in real-world settings. It has been cleared by regulatory authorities around the world, including the U.S. Food and Drug Administration (FDA), and is reimbursed by government and private payors in the U.S.”

Dr. Patrick Godard, Chief Commercial Officer at Vertice MedTech, commented, “Diabetic Retinopathy is a growing problem, and Artificial Intelligence (AI) in medical diagnostics signals a new era. Vertice EyeCare is excited to offer the cutting-edge EyeArt AI system in South Africa. The EyeArt AI system provides automated screening in a single office visit by utilising AI algorithms to assess retina images in compliance with international standards. Early identification and treatment can reduce the burden of sight-threatening retinopathy, allowing clinicians to identify patients who require immediate medical treatment without having to worry about mydriasis. Vertice MedTech believes that deploying world-class healthcare innovations such as the EyeArt AI system allows for optimising patient treatment and care.”

About Discovery
Discovery Limited is a South African-founded financial services organisation that operates in the healthcare, life assurance, short-term insurance, savings and investment and wellness markets. Since inception in 1992, Discovery has been guided by a clear core purpose – to make people healthier and to enhance and protect their lives. This has manifested in its globally recognised Vitality Shared-Value insurance model, active in 31 markets with over 20 million members. The model is exported and scaled through the Global Vitality Network, an alliance of some of the largest insurers across key markets including AIA (Asia), Ping An (China), Generali (Europe), Sumitomo (Japan), John Hancock (US), Manulife (Canada), among others. Discovery trades on the Johannesburg Securities Exchange as DSY.
Follow us on Twitter @Discovery_SA

About Vertice MedTech
Vertice MedTech is a collection of South African companies with specialist skill sets, an established track record with defined medical focus areas with many years of practical skill and with experience in several medical specialities, which it offers to identified stakeholders to achieve best medical industry practise and best possible healthcare delivery to African patients. Vertice’s medium-term strategy is to become the leading specialised MedTech group in South Africa and Sub-Saharan Africa. This strategy is being implemented through a buy and build investment thesis augmented by digitisation and support function optimisation. Ethos and the Vertice management team are working together to ensure that Vertice implements operational excellence for each of Vertice’s businesses and has the resources (people, capital, etc) to successfully execute the strategy and establish governance that embeds executive freedom within accountability to the board.

About Eyenuk, Inc.
Eyenuk, Inc. is a global artificial intelligence (AI) medical technology and services company and the leader in real-world AI Eye Screening™ for autonomous disease detection and AI Predictive Biomarkers™ for risk assessment and disease surveillance. Eyenuk is on a mission to screen every eye in the world to ensure timely diagnosis of life- and vision-threatening diseases, including diabetic retinopathy, glaucoma, age-related macular degeneration, stroke risk, cardiovascular risk, and Alzheimer’s disease. Find Eyenuk online on its websiteTwitterFacebook, and LinkedIn.

About the EyeArt AI System
The EyeArt AI System provides fully autonomous diabetic retinopathy (DR) screening, including retinal imaging, DR detection based on international clinical standards and immediate reporting, in a single office visit during a diabetic patient’s regular exam. Once the patient’s fundus images have been captured and submitted to the EyeArt AI System, the DR detection results are available in a PDF report in less than 30 seconds.

The EyeArt AI System was developed with funding from the U.S. National Institutes of Health (NIH) and is validated by the U.K. National Health Service (NHS). In addition to U.S. Food and Drug Administration (FDA) 510(k) clearance, the EyeArt AI System has CE marking as a class 2a medical device in the European Union and a Health Canada license. It is designed to be General Data Protection Regulation (GDPR) and Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.

The EyeArt AI System is reimbursable by government and private payors in the U.S. under the newly created Category 1 Current Procedural Terminology (CPT) code 92229.

VIDEO: Learn more about the EyeArt AI System for Autonomous Detection of Diabetic Retinopathy

Discovery Contacts
Karishma Jivan
Reputation Consultant
Healthcare & Sustainability
karishmaj2@discovery.co.za

Nthabiseng Chapeshamano
Press Contact
Senior Reputation Manager
Healthcare & Sustainability
nthabisengc@discovery.co.za

Eyenuk, Inc. Contact
Frank Cheng, President & CCO
frank.cheng@eyenuk.com
+1 818 835 3585

Delphix, Unisys Transform California State University’s Digital Strategy With Fast, Secure Data for Application Development

Hybrid-Architecture Strategy Includes Data Migration to AWS for All 23 Campuses

REDWOOD CITY, Calif., Dec. 07, 2021 (GLOBE NEWSWIRE) — Delphix, an industry-leading data company for DevOps, and Unisys Corporation (NYSE: UIS), a global IT solutions company, today announced that they have accelerated California State University’s (CSU) digital strategy by providing quick and secure access to data to support student application development.

The nation’s largest four-year public university can now provide its 23 campuses with data on-demand to implement their own digital strategies. This kind of rapid access has enabled software engineers at the campuses to quickly develop innovative applications to enable Graduation Initiative 2025, an ambitious project that aims to increase graduation rates while eliminating opportunity and achievement gaps. The project also includes applications that enable students to check their grades, financial aid, graduation status, etc.

The initiative is a part of the university’s larger hybrid architecture strategy aimed at improving graduation rates, student experience and satisfaction, and eliminating equity gaps in graduation rates.

Hybrid architecture Strategy
Unisys enables CSU to leverage the Delphix DevOps Data Platform to accelerate and simplify its Hybrid-Architecture enablement. The platform’s ability to easily spin up, refresh, and tear down private and public cloud-based data environments dramatically enhances the university’s application delivery pipeline.

“Using Delphix and Unisys to implement our hybrid architecture strategy allows us, for the first time, to create a unified and secure data lake, populated daily with data from all 23 campuses. This makes the data easily accessible and quickly consumable at a large scale. Our data analysts, data scientists, and developers can now drive faster innovation and proactively establish student support programs to improve graduation rates,” said Michael Berman, CIO at CSU.

The university’s hybrid architecture strategy includes data migration from an on-premise Common Management System (CMS) to Amazon Web Services (AWS), across all campuses. The CMS serves nearly 500,000 students and 56,000 faculty and staff, and is critical to everything from student enrollment, student management, scheduling, and registration to human resources, financials, and employee compensation.

“We are pleased CSU and Unisys selected AWS as a strategic cloud provider to power its digital transformation,” said Kim Majerus, Vice President, US Education, State and Local Government at AWS. “Moving to AWS can help CSU become more agile and empower them to use data more strategically to gain valuable insights that will improve the student experience. In addition, it can help the university system scale faster, reduce technical debt, realize cost savings, and manage operations more efficiently.”

Impact on Cost and Efficiency
Delphix and Unisys work together with CSU to help the university reduce costs and improve operational efficiency.

Using Delphix and Unisys, CSU has saved over $4.5M per year and avoided future costs of over $7M per year in data storage expenditures, thus freeing up resources to fund innovation. The initiative has also significantly improved CSU’s productivity measures.

  • The Delphix DevOps Data Platform delivers virtual masked copies of the CMS production data on-demand, using a fraction of the storage space compared to physical data storage. This has helped Unisys reduce CSU’s physical storage consumption while allowing its campuses to use self-service to clone and manipulate their data.
  • Delphix’s data automation helps Unisys deliver data faster and more frequently to CSU’s campuses. The application teams can now instantly refresh copies with updated production data, rewind data to any previous point in time, and branch out data copies so data versions align with release versions, all of which dramatically improve productivity.

“We are proud to partner with Delphix to enable CSU’s hybrid architecture strategy to provide improved data delivery, data access, and data integration to better support the digital strategies at CSU,” said Rudy Gonzalez, Unisys CSU Program Director. “We remain committed to helping CSU have much greater agility to execute digital cloud strategies to better serve the campuses and improve the student experience.”

Jedidiah Yueh, Delphix CEO, added, “Transformational automation is a game-changer, enabling 100x increases in innovation velocity. Modern data automation with integrated security and compliance enables CSU to improve student outcomes and experiences, spend less on infrastructure, and invest more in strategic initiatives.”

About Delphix
Delphix is the industry leading data company for DevOps.

Data is critical for testing application releases, modernization, cloud adoption, and AI/ML programs. We provide an automated DevOps data platform for all enterprise applications. Delphix masks data for privacy compliance, secures data from ransomware, and delivers efficient, virtualized data for CI/CD.

Our platform includes essential DevOps APIs for data provisioning, refresh, rewind, integration, and version control. Leading companies, including Choice Hotels, J.B.Hunt, and Fannie Mae, use Delphix to accelerate digital transformation. For more information, visit www.delphix.com or follow us on LinkedInTwitter, and Facebook.

About Unisys
Unisys is a global IT solutions company that delivers successful outcomes for the most demanding businesses and governments. Unisys offerings include digital workplace solutions, cloud and infrastructure solutions, enterprise computing solutions, business process solutions and cybersecurity solutions. For more information on how Unisys delivers for its clients across the commercial, financial services and government markets, visit www.unisys.com.

Follow Unisys on Twitter and LinkedIn.

Contact information:
Orlando de Bruce
VP of Corporate Marketing & Brand
Orlando.Debruce@delphix.com

Lantronix Named Member of the Qualcomm Automotive Solutions Ecosystem Program

A long-time member of the Qualcomm Advantage Network, Lantronix joined the invitation-only program to help accelerate automotive innovation

IRVINE, Calif., Dec. 07, 2021 (GLOBE NEWSWIRE) — Lantronix Inc. (NASDAQ: LTRX), a global provider of secure turnkey solutions for the Intelligent IT and the Internet of Things (IoT), today announced it has been named a member of the Qualcomm® Authorized Design Center Program’s automotive program. A long-time Qualcomm® Advantage Network member, Lantronix joined the invitation-only program, which assists companies in accelerating innovation by connecting customers with an ecosystem of businesses that provide tools and deep expert design services. Lantronix will participate in the automotive program, referred to as the Qualcomm® Automotive Solutions Ecosystem Program, by providing access to tools that are built around the 3rd Generation Snapdragon® Automotive Cockpit Platform, a product of Qualcomm Technologies, Inc.

“We are proud to be named a member of the Qualcomm Authorized Design Center’s Automotive Solutions Ecosystem Program, which will bring engineering and design expertise to our mutual customers while helping fast-track innovation,” said Paul Pickle, CEO of Lantronix. “With the program, Lantronix is positioned to accelerate the commercialization of automotive products, which will include customization, optimization and other design and integration services built around the 3rd Generation Snapdragon Automotive Cockpit Platforms.”

The 3rd Generation Snapdragon Automotive Cockpit Platforms are artificial intelligence (AI)-based and some of the most advanced automotive platforms from Qualcomm Technologies. Designed to support software-rich integrated cockpits engineered to meet stringent automotive industry standards, 3rd Generation Snapdragon Automotive Cockpit Platforms are engineered with immersive graphics, multimedia, computer vision and advanced AI capabilities. The Snapdragon Automotive Cockpit Platforms also provide fully scalable architecture with differentiated experiences, utilizing the same software architecture and framework to allow consumers to enjoy a harmonized user experience independent of the vehicle tier while utilizing the same software framework.

Lantronix’s inclusion in the Qualcomm Automotive Solutions Ecosystem Program, as well as its team’s proven expertise and collaboration over the years, reinforces its commitment to providing cutting-edge development services with Qualcomm Technologies for its global customers focused on the Snapdragon Automotive Cockpit platform.

About Lantronix

Lantronix Inc. is a global provider of secure turnkey solutions for the Internet of Things (IoT) and Remote Environment Management (REM), offering Software as a Service (SaaS), connectivity services, engineering services and intelligent hardware.

Lantronix enables its customers to accelerate time to market and increase operational up-time and efficiency by providing reliable, secure and connected Intelligent Edge IoT and Remote Management Gateway solutions.

Lantronix’s products and services dramatically simplify the creation, development, deployment and management of IoT and IT projects across Robotics, Automotive, Wearables, Video Conferencing, Industrial, Medical, Logistics, Smart Cities, Security, Retail, Branch Office, Server Room, and Datacenter applications. For more information, visit the Lantronix website.

Learn more at the Lantronix blog, which features industry discussion and updates. Follow Lantronix on Twitter, view our YouTube video library or connect with us on LinkedIn.

“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: Any statements set forth in this news release that are not entirely historical and factual in nature, including without limitation statements related to our solutions, technologies and products. These forward-looking statements are based on our current expectations and are subject to substantial risks and uncertainties that could cause our actual results, future business, financial condition, or performance to differ materially from our historical results or those expressed or implied in any forward-looking statement contained in this news release. The potential risks and uncertainties include, but are not limited to, such factors as the effects of negative or worsening regional and worldwide economic conditions or market instability on our business, including effects on purchasing decisions by our customers; the impact of the COVID-19 outbreak on our employees, supply and distribution chains, and the global economy; cybersecurity risks; changes in applicable U.S. and foreign government laws, regulations, and tariffs; our ability to successfully implement our acquisitions strategy or integrate acquired companies; difficulties and costs of protecting patents and other proprietary rights; the level of our indebtedness, our ability to service our indebtedness and the restrictions in our debt agreements; and any additional factors included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2020, filed with the Securities and Exchange Commission (the “SEC”) on September 11, 2020, including in the section entitled “Risk Factors” in Item 1A of Part I of such report, as well as in our other public filings with the SEC. Additional risk factors may be identified from time to time in our future filings. The forward-looking statements included in this release speak only as of the date hereof, and we do not undertake any obligation to update these forward-looking statements to reflect subsequent events or circumstances.

© 2021 Lantronix, Inc. All rights reserved. Lantronix is a registered trademark. Other trademarks and trade names are those of their respective owners.

Snapdragon Automotive Cockpit Platform is a product of Qualcomm Technologies, Inc. and/or its subsidiaries. Qualcomm Authorized Design Center Program, Qualcomm Automotive Solutions Ecosystem Program, and Qualcomm Advantage Network are programs of Qualcomm Technologies, Inc. and/or its subsidiaries.

Qualcomm and Snapdragon are trademarks or registered trademarks of Qualcomm Incorporated.

Lantronix Media Contact:
Gail Kathryn Miller
Corporate Marketing &
Communications Manager
media@lantronix.com
949-453-7158

Lantronix Analyst and Investor Contact:
Jeremy Whitaker
Chief Financial Officer
investors@lantronix.com
949-450-7241

Lantronix Sales:
sales@lantronix.com
Americas +1 (800) 422-7055 (US and Canada) or +1 949-453-3990
Europe, Middle East and Africa +31 (0)76 52 36 744
Asia Pacific + 852 3428-2338
China + 86 21-6237-8868
Japan +81 (0) 50-1354-6201
India +91 994-551-2488

Antidepressants Market to Touch USD 18.29 Billion by 2027; Growing Awareness about Mental Health Conditions to Fuel the Market: Fortune Business Insights™

Published by
Newstrail

The global antidepressants market size is projected to reach USD 18.29 billion by 2027, exhibiting a CAGR of 2.9% during the forecast period. The skyrocketing demand for depression management drugs amid the COVID-19 pandemic will rapidly broaden the horizons of this market, observes Fortune Business Insights™ in its report, titled “Antidepressants Market Size, Share & Industry Analysis, By Drug Class (Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs), Atypical Antidepressants, Tricyclic Antidepressants (TCAs), and Atypical Antipsychotics)… Continue reading “Antidepressants Market to Touch USD 18.29 Billion by 2027; Growing Awareness about Mental Health Conditions to Fuel the Market: Fortune Business Insights™”

Philips again recognized with prestigious ‘A’ score for its climate action leadership

December 7, 2021

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the company has been recognized for its climate action leadership by global environmental non-profit CDP. Thanks to its actions to cut emissions, mitigate climate risks, and develop the low-carbon economy, Philips has secured a place on CDP’s ‘A List’ for the ninth consecutive year.

“With health systems and consumers increasingly committed to making more sustainable choices and to climate action, we remain convinced that doing business sustainably is the only way forward,” said Frans van Houten, CEO of Royal Philips. “Our ongoing actions to embed sustainability in our solutions, our operations and across the supply chain, have once again been recognized with a place on CDP’s prestigious benchmark. I am proud that the creativity and inspiration of our global workforce continues to make a difference in creating a healthier and more sustainable world.”

CDP’s annual environmental disclosure and scoring process is widely recognized as the gold standard of corporate environmental transparency. Its scoring methodology assesses companies on the comprehensiveness of their disclosure, awareness and management of environmental risks and demonstration of best practices associated with environmental leadership, such as setting ambitious and meaningful targets.

Global recognition
To achieve its vision of making the world healthier and more sustainable through innovation, Philips employs a comprehensive set of commitments across all the Environmental, Social and Governance (ESG) dimensions that guide the execution of company strategy. Philips is already carbon neutral in its operations and is set to further reduce its CO2 emissions in line with 1.5°C global warming, for example by further improving the energy efficiency of its products during the customer use phase and teaming up with customers and stakeholders to decarbonize healthcare. The company has also set ambitious circular economy objectives, such as generating 25% of its revenue from circular products, services and solutions by 2025. Philips is also taking action to drive significant reduction of greenhouse gas emissions in its supply chain.

The company’s longstanding commitment to doing business responsibly and sustainably has received widespread recognition. For example, Philips has achieved top positions in the global Dow Jones Sustainability Indices and Sustainalytics rankings, and the company was awarded a top ESG score of 90 out of 100 by S&P Global Ratings. Moreover, Philips was the first health technology company to have its carbon emission targets for the 2020 – 2040 period assessed and approved by the Science-Based Targets initiative (STBi).

More information about how Philips is partnering with stakeholders to drive environmental, social and governance priorities and make a global impact, is available here.

For further information, please contact:

Joost Maltha
Philips Global Press Office
Tel: +31 610 558 116
Email: joost.maltha@philips.com

Derya Guzel
Philips Investor Relations
Tel.: +31 20 59 77055
E-mail: derya.guzel@philips.com

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2020 sales of EUR 17.3 billion and employs approximately 78,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Attachment

US diplomatic boycott: What does it mean for the Olympics?

Published by
AFP

Beijing (AFP) – The United States has announced a diplomatic boycott of the Beijing Winter Olympics to protest China’s human rights record, particularly its handling of Muslim minorities that Washington considers a form of genocide. Here’s what the move means. What is a ‘diplomatic boycott?’Under the boycott, the Biden administration will not send any US diplomatic or official governmental representatives to the Games. Olympic hosts have traditionally basked in the global attention, which often includes visits by foreign leaders or officials. US President George W. Bush, for example, cheered o… Continue reading “US diplomatic boycott: What does it mean for the Olympics?”